{
  "experiment_id": "b7a361eb65122ec855ce1f6334772067",
  "task_name": "broadening_of_narrow_synonyms",
  "task_hash": "a2c885aa2a82bb5b150f213062bbeb89",
  "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
  "system_instructions": "You are a metadata curation assistant. Your task is to help improve and correct metadata \naccording to the specific instructions provided for each task. Be precise, accurate, and \nfollow the guidelines carefully.\n",
  "temperature": 0.0,
  "thinking": false,
  "timestamp": "2025-11-13T04:52:59.512071",
  "task_result": {
    "task_name": "broadening_of_narrow_synonyms",
    "num_samples": 10,
    "results": [
      {
        "sample_index": 0,
        "input": {
          "diagnosis": "Neurofibromatosis type 1 microdeletion syndrome",
          "assay": "clinical whole-exome sequencing",
          "tumorType": "Plexiform neurofibroma (morphologic abnormality)"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"whole exome sequencing\",\n  \"tumorType\": \"Plexiform Neurofibroma\"\n}\n```",
          "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
          "usage": {
            "input_tokens": 3052,
            "cache_creation_input_tokens": 0,
            "cache_read_input_tokens": 0,
            "output_tokens": 59
          },
          "attempt": 1,
          "raw_response": {
            "model": "claude-sonnet-4-5-20250929",
            "id": "msg_bdrk_0198GtWJWD64PyupLedYzuMH",
            "type": "message",
            "role": "assistant",
            "content": [
              {
                "type": "text",
                "text": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"whole exome sequencing\",\n  \"tumorType\": \"Plexiform Neurofibroma\"\n}\n```"
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3052,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 59
            }
          }
        },
        "score": 1.0,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "whole exome sequencing",
          "tumorType": "Plexiform Neurofibroma"
        },
        "token_usage": {
          "input_tokens": 3052,
          "output_tokens": 59,
          "total_tokens": 3111
        }
      },
      {
        "sample_index": 1,
        "input": {
          "diagnosis": "Neurofibromatosis type 1 with optic pathway glioma",
          "assay": "Illumina whole exome sequencing ",
          "tumorType": "malignant triton tumor"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"whole exome sequencing\",\n  \"tumorType\": \"Malignant Peripheral Nerve Sheath Tumor\"\n}\n```\n\n**Explanation of corrections:**\n\n1. **diagnosis**: \"Neurofibromatosis type 1 with optic pathway glioma\" \u2192 \"Neurofibromatosis type 1\"\n   - Broadened from a specific subtype with comorbidity to the general diagnosis category that matches the controlled terminology.\n\n2. **assay**: \"Illumina whole exome sequencing \" \u2192 \"whole exome sequencing\"\n   - Removed the platform-specific vendor name (Illumina) and trailing space to match the broader, standardized assay term in the controlled vocabulary.\n\n3. **tumorType**: \"malignant triton tumor\" \u2192 \"Malignant Peripheral Nerve Sheath Tumor\"\n   - Malignant triton tumor is a specific subtype of MPNST (characterized by rhabdomyoblastic differentiation). Broadened to the general category that exists in the controlled terminology.",
          "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
          "usage": {
            "input_tokens": 3047,
            "cache_creation_input_tokens": 0,
            "cache_read_input_tokens": 0,
            "output_tokens": 272
          },
          "attempt": 1,
          "raw_response": {
            "model": "claude-sonnet-4-5-20250929",
            "id": "msg_bdrk_01Y2vkAYcYFvnVL5BPpVXyse",
            "type": "message",
            "role": "assistant",
            "content": [
              {
                "type": "text",
                "text": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"whole exome sequencing\",\n  \"tumorType\": \"Malignant Peripheral Nerve Sheath Tumor\"\n}\n```\n\n**Explanation of corrections:**\n\n1. **diagnosis**: \"Neurofibromatosis type 1 with optic pathway glioma\" \u2192 \"Neurofibromatosis type 1\"\n   - Broadened from a specific subtype with comorbidity to the general diagnosis category that matches the controlled terminology.\n\n2. **assay**: \"Illumina whole exome sequencing \" \u2192 \"whole exome sequencing\"\n   - Removed the platform-specific vendor name (Illumina) and trailing space to match the broader, standardized assay term in the controlled vocabulary.\n\n3. **tumorType**: \"malignant triton tumor\" \u2192 \"Malignant Peripheral Nerve Sheath Tumor\"\n   - Malignant triton tumor is a specific subtype of MPNST (characterized by rhabdomyoblastic differentiation). Broadened to the general category that exists in the controlled terminology."
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3047,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 272
            }
          }
        },
        "score": 1.0,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "whole exome sequencing",
          "tumorType": "Malignant Peripheral Nerve Sheath Tumor"
        },
        "token_usage": {
          "input_tokens": 3047,
          "output_tokens": 272,
          "total_tokens": 3319
        }
      },
      {
        "sample_index": 2,
        "input": {
          "diagnosis": "Watson Syndrome",
          "assay": "MGI whole genome sequencing",
          "tumorType": "Malignant Peripheral Nerve Sheath Tumor with Mesenchymal Differentiation"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"whole genome sequencing\",\n  \"tumorType\": \"Malignant Peripheral Nerve Sheath Tumor\"\n}\n```\n\n**Explanation of corrections:**\n\n1. **diagnosis**: \"Watson Syndrome\" \u2192 \"Neurofibromatosis type 1\"\n   - Watson Syndrome is a rare variant/subtype of Neurofibromatosis type 1 characterized by NF1, pulmonary stenosis, and cognitive impairment. It is broadened to the standard term \"Neurofibromatosis type 1\".\n\n2. **assay**: \"MGI whole genome sequencing\" \u2192 \"whole genome sequencing\"\n   - The specific platform/vendor name \"MGI\" is removed to use the broader, standard assay term from the controlled vocabulary.\n\n3. **tumorType**: \"Malignant Peripheral Nerve Sheath Tumor with Mesenchymal Differentiation\" \u2192 \"Malignant Peripheral Nerve Sheath Tumor\"\n   - The specific subtype qualifier \"with Mesenchymal Differentiation\" is removed to use the broader, standard tumor type term from the controlled vocabulary.",
          "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
          "usage": {
            "input_tokens": 3046,
            "cache_creation_input_tokens": 0,
            "cache_read_input_tokens": 0,
            "output_tokens": 290
          },
          "attempt": 1,
          "raw_response": {
            "model": "claude-sonnet-4-5-20250929",
            "id": "msg_bdrk_01TsyKRdzhLQcj4feYDowVTx",
            "type": "message",
            "role": "assistant",
            "content": [
              {
                "type": "text",
                "text": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"whole genome sequencing\",\n  \"tumorType\": \"Malignant Peripheral Nerve Sheath Tumor\"\n}\n```\n\n**Explanation of corrections:**\n\n1. **diagnosis**: \"Watson Syndrome\" \u2192 \"Neurofibromatosis type 1\"\n   - Watson Syndrome is a rare variant/subtype of Neurofibromatosis type 1 characterized by NF1, pulmonary stenosis, and cognitive impairment. It is broadened to the standard term \"Neurofibromatosis type 1\".\n\n2. **assay**: \"MGI whole genome sequencing\" \u2192 \"whole genome sequencing\"\n   - The specific platform/vendor name \"MGI\" is removed to use the broader, standard assay term from the controlled vocabulary.\n\n3. **tumorType**: \"Malignant Peripheral Nerve Sheath Tumor with Mesenchymal Differentiation\" \u2192 \"Malignant Peripheral Nerve Sheath Tumor\"\n   - The specific subtype qualifier \"with Mesenchymal Differentiation\" is removed to use the broader, standard tumor type term from the controlled vocabulary."
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3046,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 290
            }
          }
        },
        "score": 1.0,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "whole genome sequencing",
          "tumorType": "Malignant Peripheral Nerve Sheath Tumor"
        },
        "token_usage": {
          "input_tokens": 3046,
          "output_tokens": 290,
          "total_tokens": 3336
        }
      },
      {
        "sample_index": 3,
        "input": {
          "diagnosis": "neurofibromatosis, familial spinal",
          "assay": "open MRI",
          "tumorType": "unknown - no information available"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"conventional MRI\",\n  \"tumorType\": \"Unknown\"\n}\n```\n\n**Explanation of corrections:**\n\n1. **diagnosis**: \"neurofibromatosis, familial spinal\" \u2192 \"Neurofibromatosis type 1\"\n   - Familial spinal neurofibromatosis is a variant presentation of NF1, so the broader standard term is \"Neurofibromatosis type 1\"\n\n2. **assay**: \"open MRI\" \u2192 \"conventional MRI\"\n   - \"Open MRI\" is a specific type of MRI scanner configuration; the broader standard assay term is \"conventional MRI\"\n\n3. **tumorType**: \"unknown - no information available\" \u2192 \"Unknown\"\n   - Standardized to the exact enum value \"Unknown\" from the controlled terminology",
          "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
          "usage": {
            "input_tokens": 3034,
            "cache_creation_input_tokens": 0,
            "cache_read_input_tokens": 0,
            "output_tokens": 214
          },
          "attempt": 1,
          "raw_response": {
            "model": "claude-sonnet-4-5-20250929",
            "id": "msg_bdrk_014zqnwHyu3P3LbRgD9kaZgP",
            "type": "message",
            "role": "assistant",
            "content": [
              {
                "type": "text",
                "text": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"conventional MRI\",\n  \"tumorType\": \"Unknown\"\n}\n```\n\n**Explanation of corrections:**\n\n1. **diagnosis**: \"neurofibromatosis, familial spinal\" \u2192 \"Neurofibromatosis type 1\"\n   - Familial spinal neurofibromatosis is a variant presentation of NF1, so the broader standard term is \"Neurofibromatosis type 1\"\n\n2. **assay**: \"open MRI\" \u2192 \"conventional MRI\"\n   - \"Open MRI\" is a specific type of MRI scanner configuration; the broader standard assay term is \"conventional MRI\"\n\n3. **tumorType**: \"unknown - no information available\" \u2192 \"Unknown\"\n   - Standardized to the exact enum value \"Unknown\" from the controlled terminology"
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3034,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 214
            }
          }
        },
        "score": 1.0,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "conventional MRI",
          "tumorType": "Unknown"
        },
        "token_usage": {
          "input_tokens": 3034,
          "output_tokens": 214,
          "total_tokens": 3248
        }
      },
      {
        "sample_index": 4,
        "input": {
          "diagnosis": "Not Applicable",
          "assay": "immunohistochemistry of skin",
          "tumorType": "Cutaneous storiform neurofibroma"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Not Applicable\",\n  \"assay\": \"immunohistochemistry\",\n  \"tumorType\": \"Cutaneous Neurofibroma\"\n}\n```\n\n**Changes made:**\n\n1. **assay**: Broadened \"immunohistochemistry of skin\" to \"immunohistochemistry\" - removed the tissue-specific qualifier to match the standard controlled terminology.\n\n2. **tumorType**: Broadened \"Cutaneous storiform neurofibroma\" to \"Cutaneous Neurofibroma\" - removed the specific histological subtype qualifier \"storiform\" to match the standard controlled terminology for cutaneous neurofibromas.\n\n3. **diagnosis**: Kept as \"Not Applicable\" - already matches the controlled terminology exactly.",
          "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
          "usage": {
            "input_tokens": 3034,
            "cache_creation_input_tokens": 0,
            "cache_read_input_tokens": 0,
            "output_tokens": 180
          },
          "attempt": 1,
          "raw_response": {
            "model": "claude-sonnet-4-5-20250929",
            "id": "msg_bdrk_01CQSHTTfvUU6dRqEt7dx549",
            "type": "message",
            "role": "assistant",
            "content": [
              {
                "type": "text",
                "text": "```json\n{\n  \"diagnosis\": \"Not Applicable\",\n  \"assay\": \"immunohistochemistry\",\n  \"tumorType\": \"Cutaneous Neurofibroma\"\n}\n```\n\n**Changes made:**\n\n1. **assay**: Broadened \"immunohistochemistry of skin\" to \"immunohistochemistry\" - removed the tissue-specific qualifier to match the standard controlled terminology.\n\n2. **tumorType**: Broadened \"Cutaneous storiform neurofibroma\" to \"Cutaneous Neurofibroma\" - removed the specific histological subtype qualifier \"storiform\" to match the standard controlled terminology for cutaneous neurofibromas.\n\n3. **diagnosis**: Kept as \"Not Applicable\" - already matches the controlled terminology exactly."
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3034,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 180
            }
          }
        },
        "score": 1.0,
        "ground_truth": {
          "diagnosis": "Not Applicable",
          "assay": "immunohistochemistry",
          "tumorType": "Cutaneous Neurofibroma"
        },
        "token_usage": {
          "input_tokens": 3034,
          "output_tokens": 180,
          "total_tokens": 3214
        }
      },
      {
        "sample_index": 5,
        "input": {
          "diagnosis": "chromosome 17q11.2 deletion syndrome, 1.4Mb",
          "assay": "cell viability assay using Annexin V staining",
          "tumorType": "Pedunculated Cutaneous Neurofibroma"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"cell viability assay\",\n  \"tumorType\": \"Cutaneous Neurofibroma\"\n}\n```\n\n**Explanation of corrections:**\n\n1. **diagnosis**: \"chromosome 17q11.2 deletion syndrome, 1.4Mb\" is a specific genetic description of Neurofibromatosis type 1 (NF1), which is caused by deletions in the NF1 gene located at chromosome 17q11.2. This has been broadened to the standard term **\"Neurofibromatosis type 1\"**.\n\n2. **assay**: \"cell viability assay using Annexin V staining\" is a specific method of performing a cell viability assay. This has been broadened to the general term **\"cell viability assay\"** which is the exact value from the controlled terminology.\n\n3. **tumorType**: \"Pedunculated Cutaneous Neurofibroma\" is a specific morphological subtype of cutaneous neurofibroma. This has been broadened to the standard term **\"Cutaneous Neurofibroma\"** from the controlled vocabulary.",
          "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
          "usage": {
            "input_tokens": 3056,
            "cache_creation_input_tokens": 0,
            "cache_read_input_tokens": 0,
            "output_tokens": 283
          },
          "attempt": 1,
          "raw_response": {
            "model": "claude-sonnet-4-5-20250929",
            "id": "msg_bdrk_01B9fgxgZ8xuM1RaB61KsEkM",
            "type": "message",
            "role": "assistant",
            "content": [
              {
                "type": "text",
                "text": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"cell viability assay\",\n  \"tumorType\": \"Cutaneous Neurofibroma\"\n}\n```\n\n**Explanation of corrections:**\n\n1. **diagnosis**: \"chromosome 17q11.2 deletion syndrome, 1.4Mb\" is a specific genetic description of Neurofibromatosis type 1 (NF1), which is caused by deletions in the NF1 gene located at chromosome 17q11.2. This has been broadened to the standard term **\"Neurofibromatosis type 1\"**.\n\n2. **assay**: \"cell viability assay using Annexin V staining\" is a specific method of performing a cell viability assay. This has been broadened to the general term **\"cell viability assay\"** which is the exact value from the controlled terminology.\n\n3. **tumorType**: \"Pedunculated Cutaneous Neurofibroma\" is a specific morphological subtype of cutaneous neurofibroma. This has been broadened to the standard term **\"Cutaneous Neurofibroma\"** from the controlled vocabulary."
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3056,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 283
            }
          }
        },
        "score": 1.0,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "cell viability assay",
          "tumorType": "Cutaneous Neurofibroma"
        },
        "token_usage": {
          "input_tokens": 3056,
          "output_tokens": 283,
          "total_tokens": 3339
        }
      },
      {
        "sample_index": 6,
        "input": {
          "diagnosis": "Neurofibromatosis type 1 with scoliosis",
          "assay": "anti-tag immunocytochemistry",
          "tumorType": "sessile cutaneous neurofibroma"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"immunocytochemistry\",\n  \"tumorType\": \"Cutaneous Neurofibroma\"\n}\n```",
          "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
          "usage": {
            "input_tokens": 3047,
            "cache_creation_input_tokens": 0,
            "cache_read_input_tokens": 0,
            "output_tokens": 58
          },
          "attempt": 1,
          "raw_response": {
            "model": "claude-sonnet-4-5-20250929",
            "id": "msg_bdrk_01SrjnXKAyZf3WkXFU7z9cKV",
            "type": "message",
            "role": "assistant",
            "content": [
              {
                "type": "text",
                "text": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"immunocytochemistry\",\n  \"tumorType\": \"Cutaneous Neurofibroma\"\n}\n```"
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3047,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 58
            }
          }
        },
        "score": 1.0,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "immunocytochemistry",
          "tumorType": "Cutaneous Neurofibroma"
        },
        "token_usage": {
          "input_tokens": 3047,
          "output_tokens": 58,
          "total_tokens": 3105
        }
      },
      {
        "sample_index": 7,
        "input": {
          "diagnosis": "neurofibromatosis, peripheral type",
          "assay": "wide bore MRI",
          "tumorType": "no clear diagnosis"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"conventional MRI\",\n  \"tumorType\": \"Unknown\"\n}\n```\n\n**Explanation of corrections:**\n\n1. **diagnosis**: \"neurofibromatosis, peripheral type\" \u2192 \"Neurofibromatosis type 1\"\n   - Peripheral neurofibromatosis is the historical term for NF1, which is the standard terminology in the controlled vocabulary.\n\n2. **assay**: \"wide bore MRI\" \u2192 \"conventional MRI\"\n   - Wide bore MRI is a specific type of MRI scanner (referring to the bore diameter), but the assay type itself is conventional MRI. The controlled vocabulary uses \"conventional MRI\" as the standard term for basic structural MRI imaging.\n\n3. **tumorType**: \"no clear diagnosis\" \u2192 \"Unknown\"\n   - When there is no clear diagnosis or the tumor type cannot be determined, the standard controlled term is \"Unknown\".",
          "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
          "usage": {
            "input_tokens": 3031,
            "cache_creation_input_tokens": 0,
            "cache_read_input_tokens": 0,
            "output_tokens": 230
          },
          "attempt": 1,
          "raw_response": {
            "model": "claude-sonnet-4-5-20250929",
            "id": "msg_bdrk_01Bwy3vLZUKeQyi5XzhRC2Gu",
            "type": "message",
            "role": "assistant",
            "content": [
              {
                "type": "text",
                "text": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"conventional MRI\",\n  \"tumorType\": \"Unknown\"\n}\n```\n\n**Explanation of corrections:**\n\n1. **diagnosis**: \"neurofibromatosis, peripheral type\" \u2192 \"Neurofibromatosis type 1\"\n   - Peripheral neurofibromatosis is the historical term for NF1, which is the standard terminology in the controlled vocabulary.\n\n2. **assay**: \"wide bore MRI\" \u2192 \"conventional MRI\"\n   - Wide bore MRI is a specific type of MRI scanner (referring to the bore diameter), but the assay type itself is conventional MRI. The controlled vocabulary uses \"conventional MRI\" as the standard term for basic structural MRI imaging.\n\n3. **tumorType**: \"no clear diagnosis\" \u2192 \"Unknown\"\n   - When there is no clear diagnosis or the tumor type cannot be determined, the standard controlled term is \"Unknown\"."
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3031,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 230
            }
          }
        },
        "score": 1.0,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "conventional MRI",
          "tumorType": "Unknown"
        },
        "token_usage": {
          "input_tokens": 3031,
          "output_tokens": 230,
          "total_tokens": 3261
        }
      },
      {
        "sample_index": 8,
        "input": {
          "diagnosis": "acoustic neurofibromatosis",
          "assay": "RNA-seq with ribosomal RNA depletion",
          "tumorType": "Acoustic neuroma of left vestibular nerve"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"NF2-related schwannomatosis\",\n  \"assay\": \"RNA-seq\",\n  \"tumorType\": \"Schwannoma\"\n}\n```\n\n**Explanation of corrections:**\n\n1. **diagnosis**: \"acoustic neurofibromatosis\" is a narrow/outdated term for what is now classified as \"NF2-related schwannomatosis\" (formerly called Neurofibromatosis type 2). This condition is characterized by bilateral vestibular schwannomas.\n\n2. **assay**: \"RNA-seq with ribosomal RNA depletion\" is a specific technical variation of the broader standard assay type \"RNA-seq\". The ribosomal RNA depletion is a library preparation method detail, but the core assay type is RNA-seq.\n\n3. **tumorType**: \"Acoustic neuroma of left vestibular nerve\" is a narrow, anatomically-specific term. Acoustic neuromas are vestibular schwannomas, and the broader standard term from the controlled vocabulary is \"Schwannoma\". The anatomical location (left vestibular nerve) is a specific detail that falls under the general tumor type.",
          "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
          "usage": {
            "input_tokens": 3044,
            "cache_creation_input_tokens": 0,
            "cache_read_input_tokens": 0,
            "output_tokens": 270
          },
          "attempt": 1,
          "raw_response": {
            "model": "claude-sonnet-4-5-20250929",
            "id": "msg_bdrk_018RJhSdDzunTDc7XhXpF7He",
            "type": "message",
            "role": "assistant",
            "content": [
              {
                "type": "text",
                "text": "```json\n{\n  \"diagnosis\": \"NF2-related schwannomatosis\",\n  \"assay\": \"RNA-seq\",\n  \"tumorType\": \"Schwannoma\"\n}\n```\n\n**Explanation of corrections:**\n\n1. **diagnosis**: \"acoustic neurofibromatosis\" is a narrow/outdated term for what is now classified as \"NF2-related schwannomatosis\" (formerly called Neurofibromatosis type 2). This condition is characterized by bilateral vestibular schwannomas.\n\n2. **assay**: \"RNA-seq with ribosomal RNA depletion\" is a specific technical variation of the broader standard assay type \"RNA-seq\". The ribosomal RNA depletion is a library preparation method detail, but the core assay type is RNA-seq.\n\n3. **tumorType**: \"Acoustic neuroma of left vestibular nerve\" is a narrow, anatomically-specific term. Acoustic neuromas are vestibular schwannomas, and the broader standard term from the controlled vocabulary is \"Schwannoma\". The anatomical location (left vestibular nerve) is a specific detail that falls under the general tumor type."
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3044,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 270
            }
          }
        },
        "score": 0.6666666666666666,
        "ground_truth": {
          "diagnosis": "NF2-related schwannomatosis",
          "assay": "RNA-seq",
          "tumorType": "schwannoma"
        },
        "token_usage": {
          "input_tokens": 3044,
          "output_tokens": 270,
          "total_tokens": 3314
        }
      },
      {
        "sample_index": 9,
        "input": {
          "diagnosis": "neurofibromatosis type 1 due to NF1 mutation or intragenic deletion",
          "assay": "CellTiter-Glo\u00ae 3D Cell Viability Assay",
          "tumorType": "Epithelioid Malignant Peripheral Nerve Sheath Tumor"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"3D microtissue viability\",\n  \"tumorType\": \"Malignant Peripheral Nerve Sheath Tumor\"\n}\n```",
          "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
          "usage": {
            "input_tokens": 3077,
            "cache_creation_input_tokens": 0,
            "cache_read_input_tokens": 0,
            "output_tokens": 66
          },
          "attempt": 1,
          "raw_response": {
            "model": "claude-sonnet-4-5-20250929",
            "id": "msg_bdrk_01S7avvkmjSYbkTQvNzoEWWd",
            "type": "message",
            "role": "assistant",
            "content": [
              {
                "type": "text",
                "text": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"3D microtissue viability\",\n  \"tumorType\": \"Malignant Peripheral Nerve Sheath Tumor\"\n}\n```"
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3077,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 66
            }
          }
        },
        "score": 1.0,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "3D microtissue viability",
          "tumorType": "Malignant Peripheral Nerve Sheath Tumor"
        },
        "token_usage": {
          "input_tokens": 3077,
          "output_tokens": 66,
          "total_tokens": 3143
        }
      }
    ],
    "metrics": {
      "total_samples": 10,
      "successful_runs": 10,
      "failed_runs": 0,
      "success_rate": 1.0,
      "average_score": 0.9666666666666666,
      "min_score": 0.6666666666666666,
      "max_score": 1.0,
      "num_scored": 10
    },
    "duration_seconds": 56.14393067359924,
    "token_usage": {
      "input_tokens": 30468,
      "output_tokens": 1922,
      "total_tokens": 32390
    }
  }
}